Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price increased by equities research analysts at HC ...
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) shares hit a new 52-week high during trading on Friday after HC Wainwright raised their price target on the stock from $190.00 to $200.00. HC ...
13h
Investor's Business Daily on MSNThese Biotech Stocks Aren't Profitable But Still Make Elite IBD 50A handful of biotech stocks made an elite list despite being unprofitable. But many show robust sales growth and constructive ...
19hon MSN
Goldman Sachs analysts listed the stocks with the largest increases and decreases in short interest since the U.S. election day. Analysts looked through short interest data reflecting positions as of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results